Isavufic 200mg Tablet

Introduction

Isavufic is a prescription medication that contains the active ingredient Isavuconazole. It is available in tablet form and is used for the treatment of certain fungal infections.

Uses

Isavufic is prescribed to treat various fungal infections, including invasive aspergillosis and invasive mucormycosis. These infections can occur in individuals with weakened immune systems, such as those undergoing chemotherapy or organ transplantation.

Dosage and Administration

The dosage of Isavufic will vary depending on the specific condition being treated and the individual patient’s medical history. Follow the instructions provided by your healthcare provider. Generally, the tablets are taken orally with or without food. Take the medication as directed and complete the full course of treatment, even if you start to feel better.

Mechanism of Action

Isavuconazole, the active ingredient in Isavufic, belongs to a class of medications known as triazole antifungals. It works by inhibiting the growth of fungi that cause infections. Isavuconazole targets specific enzymes in the fungal cells, disrupting their ability to reproduce and survive.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, headache, and rash. These side effects are generally mild and should resolve on their own. However, if you experience any severe or persistent side effects, contact your healthcare provider.

Serious side effects of Isavufic are rare but may include liver problems, allergic reactions, and changes in heart rhythm. Seek immediate medical attention if you experience any signs of a severe allergic reaction, such as difficulty breathing, swelling of the face, lips, tongue, or throat, or a rash accompanied by fever, blistering, or peeling.

Drug Interactions

Isavufic may interact with other medications, including certain antibiotics, antifungals, and medications used to treat heart rhythm disorders. Inform your healthcare provider about all the medications you are currently taking, including prescription and over-the-counter drugs, as well as any herbal supplements or vitamins. They can help determine if any potential drug interactions may occur and adjust your treatment plan accordingly.

Precautions

Before taking Isavufic, inform your healthcare provider about any allergies you may have, especially to other antifungal medications. Additionally, let them know about any other medical conditions you have, such as liver or kidney problems, or if you are pregnant or breastfeeding.

Isavufic may interact with certain medications, such as rifampin and phenytoin, which may affect its effectiveness. Discuss all your current medications with your healthcare provider to ensure safe and effective treatment.

Storage

Patient Tips

• Take Isavufic exactly as prescribed by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not stop taking Isavufic without consulting your healthcare provider, even if you start to feel better. Stopping the medication prematurely may allow the infection to come back or worsen.
• If you have any questions or concerns about your treatment with Isavufic, do not hesitate to reach out to your healthcare provider for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Isavuconazole use while Breastfeeding (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
• Mucormycosis (MedlinePlus) [Accessed 1 Jun. 2024] (online) Available at:
• Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10. [Accessed 29 Jun. 2024] Available at:
• LactMed: Drugs and Lactation Database (National Library of Medicine) [Accessed 27 Jun. 2024] (online) Available at: